Topchoice Medical Co. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,916	2,859	2,832	2,697	2,758	2,083
Other Revenue	14.6	14.6	14.51	21.21	22.23	5.24
Revenue	2,931	2,874	2,847	2,719	2,781	2,088
Revenue Growth (YoY)	1.25%	0.96%	4.70%	-2.23%	33.18%	8.12%
Cost of Revenue	1,803	1,767	1,750	1,609	1,500	1,145
Gross Profit	1,128	1,107	1,097	1,110	1,281	942.99
Selling, General & Admin	359.16	348.23	338.22	312.81	283.39	247.64
Research & Development	61.01	58.95	55.65	54.03	59.13	40.06
Other Operating Expenses	9.12	4.93	6.79	6.11	7.55	4.49
Operating Expenses	434.23	415.28	402.41	374.62	351.35	292.66
Operating Income	693.35	691.34	694.35	734.97	929.37	650.34
Interest Expense	-42.79	-45.44	-55.01	-50.05	-28.91	-18.76
Interest & Investment Income	52.67	50.52	71.82	47.54	67.79	46.92
Currency Exchange Gain (Loss)	-	-	-	-	-	-0
Other Non Operating Income (Expenses)	-0.11	-5.3	-8.37	-6	-2.77	-5.26
EBT Excluding Unusual Items	703.12	691.13	702.78	726.46	965.49	673.23
Gain (Loss) on Sale of Investments	1.42	1.42	-	-	-	-
Gain (Loss) on Sale of Assets	-0.09	0.14	-	-0.05	-0.02	-
Asset Writedown	-0.86	-0.86	-0.42	-0.51	-0.21	-0.34
Other Unusual Items	7.27	2.18	6.46	12.08	9.33	7.17
Pretax Income	710.86	694.01	708.82	737.98	974.58	680.07
Income Tax Expense	123.58	121.88	130.43	122.31	188.43	135.1
Earnings From Continuing Operations	587.27	572.13	578.39	615.68	786.15	544.96
Minority Interest in Earnings	-70.12	-70.7	-77.95	-67.41	-83.34	-52.34
Net Income	517.15	501.43	500.44	548.27	702.81	492.63
Net Income to Common	517.15	501.43	500.44	548.27	702.81	492.63
Net Income Growth	6.30%	0.20%	-8.72%	-21.99%	42.67%	5.69%
Shares Outstanding (Basic)	446	447	447	449	449	448
Shares Outstanding (Diluted)	446	447	447	449	449	448
Shares Change (YoY)	-0.10%	0.15%	-0.50%	-0.09%	0.32%	-0.48%
EPS (Basic)	1.16	1.12	1.12	1.22	1.56	1.10
EPS (Diluted)	1.16	1.12	1.12	1.22	1.56	1.10
EPS Growth	6.36%	0%	-8.26%	-21.92%	42.21%	6.20%
Free Cash Flow	528	431.3	332.13	248.52	572.09	538.01
Free Cash Flow Per Share	1.18	0.96	0.74	0.55	1.27	1.20
Dividend Per Share	0.450	0.450	0.311	-	-	-
Dividend Growth	44.70%	44.70%	-	-	-	-
Gross Margin	38.47%	38.51%	38.53%	40.81%	46.06%	45.17%
Operating Margin	23.66%	24.06%	24.39%	27.03%	33.42%	31.15%
Profit Margin	17.64%	17.45%	17.58%	20.17%	25.27%	23.59%
Free Cash Flow Margin	18.02%	15.01%	11.67%	9.14%	20.57%	25.77%
EBITDA	783.15	779.18	779.55	816.57	1,001	712.99
EBITDA Margin	26.72%	27.11%	27.39%	30.04%	35.99%	34.15%
D&A For EBITDA	89.8	87.83	85.21	81.6	71.43	62.65
EBIT	693.35	691.34	694.35	734.97	929.37	650.34
EBIT Margin	23.66%	24.06%	24.39%	27.03%	33.42%	31.15%
Effective Tax Rate	17.39%	17.56%	18.40%	16.57%	19.34%	19.87%
Revenue as Reported	2,931	2,874	2,847	2,719	2,781	2,088
Advertising Expenses	-	22.93	21.54	23.41	20.87	14.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.